#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Dermatitis atopic Asthma Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chondrodystrophy Desmoid tumour Human papilloma virus immunisation Ocular lymphoma Stiff person syndrome Follicular lymphoma stage III Leukoencephalopathy Toxic epidermal necrolysis Post transplant lymphoproliferative disorder Neuromyelitis optica spectrum disorder Alport's syndrome Colorectal cancer metastatic Synovial sarcoma metastatic Asthma Porphyria non-acute More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis – Diagnostics Behcet’s syndrome – Trials in Disease Brain stem glioma Shprintzen-Goldberg syndrome – Treatment Synovial sarcoma – Trials in Disease Lymphangiosarcoma – Treatment Mucopolysaccharidosis – Trials in Disease Hereditary optic atrophy – Trials in Disease Nephrotic syndrome – Treatment Primary immunodeficiency syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Vobramitamab Duocarmazine Dc-806 Bi-1910 Cytisinicline Levocarnitine Levobupivacaine Linsitinib Nitrogen E.coli Polysaccharide Indocyanine Green Coffee Charcoal Vamorolone Ecoo4 Seladelpar Bi 690517 Gd2Il18Cart Furosemide Ag13909 ACT-1004-1239 TRONTINEMAB More therapies…

    Learn about Your Condition

    Nodular melanoma Tuberculosis Gaucher's disease type III Dizziness Osteoporosis postmenopausal Peritoneal sarcoma Epileptic encephalopathy Intestinal infarction Syphilis Extra-osseous Ewing's sarcoma Leukaemia Alopecia areata Inborn error of metabolism Joint stabilisation Interstitial lung disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Institut Paoli-Calmettes Cancer Centre

Institut Paoli-Calmettes Cancer Centre

2pz Bvxerrwia Dm Scxjrc Mynixnjbapl Bm 1qnm Mkxzrvtggn 1byktc Ffywzy

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Early vs. Late Epoetin Alfa Treatment for Adults with Low-Risk MDS and Anemia Not Requiring Blood Transfusions

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Epoetin Alfa
    France

  • Study of Nivolumab for Children and Adults with Relapsed or Refractory ALK+ Anaplastic Large Cell Lymphoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Anaplastic large cell lymphoma T- and null-cell types
    Investigated Drugs:
    • Nivolumab
    Denmark France

  • Study on Chlorambucil and Rituximab for Patients with MALT Lymphoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Extranodal marginal zone B-cell lymphoma (MALT type)
    Investigated Drugs:
    • Chlorambucil
    • Rituximab
    France Italy

  • Study of Axitinib and Pembrolizumab for Patients with Advanced or Metastatic Papillary Renal Cell Carcinoma

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Axitinib
    • Pembrolizumab
    France

  • Study on the Safety and Effectiveness of Mitazalimab with Chemotherapy for Patients with Metastatic Pancreatic Cancer

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma metastatic
    Investigated Drugs:
    • Mitazalimab
    • Calcium Folinate
    • Fluorouracil
    Belgium France Spain

  • Study on Advanced Soft-Tissue Sarcoma: Testing Futibatinib and Drug Combination for Patients with Unresectable or Metastatic Conditions

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Sarcoma
    Investigated Drugs:
    • Futibatinib
    • Glasdegib
    • Lapatinib
    France

  • Study on the Effectiveness of Durvalumab, Olaparib, and Bevacizumab in Patients with Newly Diagnosed Advanced Ovarian Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Ovarian cancer
    Investigated Drugs:
    • Bevacizumab
    • Durvalumab
    • Infliximab
    Austria Belgium Bulgaria Denmark Finland France +6

  • Study on the Effect of Cemiplimab in Patients with Oligometastatic Non-Small Cell Lung Cancer After Radical Treatment

    Not recruiting

    4 1 1
    Investigated Drugs:
    • Cemiplimab
    Belgium France Italy The Netherlands Spain

  • Study on Atezolizumab for Patients with Locally Advanced Cervical Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Cervix carcinoma
    Investigated Drugs:
    • Atezolizumab
    France

  • Study of Encorafenib and Binimetinib for Patients with BRAFV600E-Mutant Metastatic Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage IV
    Investigated Drugs:
    • Binimetinib
    • Encorafenib
    France
Previous Page
1 … 27 28 29 30 31 … 42
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!